Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related AKBA
Benzinga's Top Initiations
The Market In 5 Minutes: Carl Icahn, Mary Jo White And Rudy Giuliani Making News
Related KBH
Beazer Homes, Hovnania Enterprises Leading The Homebuilding Sector Sharply Higher
Fast Money Traders Reveal Their Picks At Market Highs
New High Analysis: Leadership Broadens Out Beyond Financials (Investor's Business Daily)

Caladrius Biosciences Inc (NASDAQ: CLBS) shares fell 32.08 percent to $0.72 in pre-market trading after the company reported that it will discontinue an ongoing Phase 3 study of CLBS20 as monotherapy for metastatic melanoma.

Epizyme Inc (NASDAQ: EPZM) shares fell 21.58 percent to $9.05 in pre-market trading after the company priced 13.33 million share offering at $9.00 per share.

Finish Line Inc (NASDAQ: FINL) shares fell 16.22 percent to $15.50 in pre-market trading after the company reported downbeat Q3 results and issued a weak earnings forecast. The company also reported that Sam Sato will succeed Glenn Lyon as CEO.

Akebia Therapeutics Inc (NASDAQ: AKBA) fell 9.38 percent to $8.70 in pre-market trading after the company priced 7.25 million share offering at $9.00 per share.

Atmel Corporation (NASDAQ: ATML) shares fell 8.28 percent to $7.86 in pre-market trading following Wednesday Bloomberg report that Microchip Technology Inc. (NASDAQ: MCHP) was reconsidering its $9.00 per share bid for Atmel.

KB Home (NYSE: KBH) shares fell 6.70 percent to $11.00 in pre-market trading after the company reported weaker-than-expected Q4 results.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (ATML + AKBA)

View Comments and Join the Discussion!